DALLAS, Nov. 19, 2025 /PRNewswire/ -- Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth Stover, Joyce Liu, and Ursula...
Hence then, the article about dialectic therapeutics announces dosing of first patient in platinum resistant ovarian cancer proc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC) )
Also on site :
- Who Is High Voltage on ‘The Masked Singer’? The Electric Clues Point One Way
- Mira Murati’s startup, Thinking Machines Lab, is losing two of its co-founders to OpenAI
- Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal